Peden K - Search Results

1

Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc.

Sheng L, Cai F, Zhu Y, Pal A, Athanasiou M, Orrison B, Blair DG, Hughes SH, Coffin JM, Lewis AM, Peden K. Sheng L, et al. Among authors: peden k. Biologicals. 2008 May;36(3):184-97. doi: 10.1016/j.biologicals.2007.11.003. Epub 2008 Jan 22. Biologicals. 2008. PMID: 18218323

2

Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.

Manohar M, Orrison B, Peden K, Lewis AM Jr. Manohar M, et al. Among authors: peden k. Biologicals. 2008 Jan;36(1):65-72. doi: 10.1016/j.biologicals.2007.06.002. Epub 2007 Oct 22. Biologicals. 2008. PMID: 17933552

3

Issues associated with residual cell-substrate DNA in viral vaccines.

Sheng-Fowler L, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. Biologicals. 2009 Jun;37(3):190-5. doi: 10.1016/j.biologicals.2009.02.015. Epub 2009 Mar 14. Biologicals. 2009. PMID: 19285882

4

Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.

Sheng-Fowler L, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. Biologicals. 2009 Aug;37(4):259-69. doi: 10.1016/j.biologicals.2009.04.002. Epub 2009 May 19. Biologicals. 2009. PMID: 19457682

5

Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Sheng-Fowler L, Cai F, Fu H, Zhu Y, Orrison B, Foseh G, Blair DG, Hughes SH, Coffin JM, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. Int J Biol Sci. 2010 Mar 29;6(2):151-62. doi: 10.7150/ijbs.6.151. Int J Biol Sci. 2010. PMID: 20376206 Free PMC article.

6

A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc.

Sheng-Fowler L, Tu W, Fu H, Murata H, Lanning L, Foseh G, Macauley J, Blair D, Hughes SH, Coffin JM, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. PLoS One. 2014 Oct 10;9(10):e108926. doi: 10.1371/journal.pone.0108926. eCollection 2014. PLoS One. 2014. PMID: 25302710 Free PMC article.

7

Biological activity of residual cell-substrate DNA.

Peden K, Sheng L, Pal A, Lewis A. Peden K, et al. Dev Biol (Basel). 2006;123:45-53; discussion 55-73. Dev Biol (Basel). 2006. PMID: 16566436

8

Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.

Murata H, Macauley J, Lewis AM Jr, Peden K. Murata H, et al. Among authors: peden k. Vaccine. 2011 Apr 12;29(17):3155-61. doi: 10.1016/j.vaccine.2011.02.041. Epub 2011 Feb 26. Vaccine. 2011. PMID: 21354480

9

A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture.

Lewis AM Jr, Krause P, Peden K. Lewis AM Jr, et al. Among authors: peden k. Dev Biol (Basel). 2001;106:513-35. Dev Biol (Basel). 2001. PMID: 11761266 No abstract available.

10

Identification of a neutralization epitope in the VP1 capsid protein of SV40.

Murata H, Teferedegne B, Sheng L, Lewis AM Jr, Peden K. Murata H, et al. Among authors: peden k. Virology. 2008 Nov 10;381(1):116-22. doi: 10.1016/j.virol.2008.07.032. Epub 2008 Sep 11. Virology. 2008. PMID: 18789470 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters